Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Drs Francesc Xavier Cos Claramunt and Carmen Hurtado, representatives of the European Diabetes Forum (EUDF), discuss the prevalence and challenges associated with diabetes management and the health-related policies needed to support prevention and early diagnosis.
Sabih Chaudhry, CEO of Afon Technology Ltd, describes the company’s innovative Glucowear™ — the world’s first non-invasive, real-time, and continuous blood glucose sensor.
Beyond the impact of the COVID-19 pandemic on routine care, other factors impact the physical and mental wellbeing of people with diabetes. Lorna Rothery spoke to Dr Mayank Patel, a consultant in diabetes at University Hospital Southampton and member of the DRWF editorial advisory board, about the importance of education in changing attitudes towards type 1 and type 2 diabetes stigma.
Researchers in Portugal look at the critical gaps in knowledge against type 2 diabetes (T2D) patients, potentially impacting their long-term health outcomes.
Diabetes represents a huge burden on health systems and sufferers, but accurately monitoring blood sugar levels could help people to take control of their health before more serious issues come to light.
35.3% of British adults are likely to have prediabetes. Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, argues that increased diabetes testing is needed to ensure 18 million people don’t go on to develop ‘full-blown’ diabetes.
Stefano Del Prato and Bart Torbeyns from the European Diabetes Forum (EUDF) outline the major challenges in preventing and managing diabetes, and the actions policymakers and health systems can take to address them.
Research conducted by the University of Surrey suggests that insulin icodec, a weekly basal injection, may be just as effective when treating type 1 diabetes compared to daily basal insulin treatments.
Metformin offers pregnant women hope as an effective alternative for gestational diabetes treatment and management worldwide
Scientists at the University of Galway have made notable...
Diabetes can pose significant implications for individuals’ mental and physical wellbeing. While new research shows promise in supporting diabetes management and care, many challenges still remain. We discussed these with Beyond Type 1’s content strategist Dr Liz Kopco.